Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-25 @ 9:26 PM
Study NCT ID:
NCT00343356
Status:
COMPLETED
Last Update Posted:
2006-06-22
First Post:
2006-06-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder
Sponsor:
LanZhou University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1996-06
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2003-07
Completion Date Type:
None
First Submit Date:
2006-06-19
First Submit QC Date:
None
Study First Post Date:
2006-06-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2006-06-21
Last Update Post Date:
2006-06-22
Last Update Post Date Type:
ESTIMATED